Adenoid hypertrophy in children
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Children aged 2 to 12 years, regardless of sex; 2) Meet the Western diagnostic criteria for adenoid hypertrophy in children; 3) All enrolled children must have a signed informed consent form provided by their parents.
Exclusion criteria
Exclusion criteria: 1) Patients with primary cardiovascular, hepatic, renal, hematopoietic, or neurological diseases; 2) Individuals with OSA-18 scale scores indicating severe sleep impairment; 3) Patients with severe nasal deformities; 4) Individuals experiencing respiratory difficulties due to causes such as obesity, nasal polyps, neuromuscular tension in the upper airway, or laryngeal and tracheal disorders; 5) Patients who have received oral or intravenous antibiotics within the past 8 weeks; 6) Individuals allergic to the treatment medications; 7) Patients unable to cooperate with blood draw procedures; 8) Individuals who have participated in other clinical trials within the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantitative Score Comparison of Nasal Congestion, Snoring, and Mouth Breathing;Size of Adenoids; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quantitative scoring of secondary symptoms and their changes;Quality of Life Assessment: OSA-18 Score; | — |
Countries
CHINA
Contacts
Guangzhou Medical University Affiliated Women and Children's Medical Center